Treating elevated intracranial pressure (ICP) involves a combination of positioning, medications, drainage procedures, and in severe cases, surgery. Normal ICP in adults ranges from 7 to 15 mmHg, and pressure above 20 to 22 mmHg is considered dangerous and typically triggers treatment. The specific approach depends on the cause, whether that’s a traumatic brain injury, stroke, tumor, or a chronic condition like idiopathic intracranial hypertension.
Why Intracranial Pressure Rises
Your skull is a rigid container holding three things: brain tissue, blood, and cerebrospinal fluid (CSF). Under normal conditions, these three components balance each other out. If one increases in volume, the others must decrease to compensate. This is why a growing tumor, bleeding, or a buildup of CSF can push pressure dangerously high: the skull simply has no room to expand. Once the body’s natural compensating mechanisms are overwhelmed, pressure climbs rapidly and can compress brain tissue, cut off blood supply, or force the brain downward through the base of the skull.
Head Positioning and Basic Measures
The simplest first step is raising the head of the bed, typically to around 30 degrees, to help blood drain from the brain through the jugular veins. That said, the ideal angle can vary from person to person, and in some patients, particularly children, clinicians adjust the position daily based on pressure readings. Keeping the head in a neutral, midline position also prevents the neck veins from being kinked or compressed, which would block drainage and raise pressure further.
Other baseline measures include controlling fever (which increases the brain’s metabolic demand and blood flow), managing pain, and avoiding agitation. Each of these can spike ICP on its own, so treating them is part of the foundation before more aggressive therapies are considered.
Osmotic Medications
When positioning and basic care aren’t enough, osmotic agents are the first-line medical treatment. These work by making the bloodstream saltier than the surrounding brain tissue, which draws water out of swollen brain cells and into the blood vessels, shrinking brain volume and lowering pressure.
The two most commonly used agents are mannitol and hypertonic saline. Mannitol is given intravenously, usually at a concentration of 20%, in doses between 0.25 and 1.0 grams per kilogram of body weight. It acts relatively quickly but can cause dehydration and kidney strain with repeated use, so blood chemistry is monitored closely. Hypertonic saline, often at a 3% concentration, works through the same osmotic principle. It tends to be infused slowly to avoid pushing sodium levels too high. Both are effective, and the choice between them often comes down to the patient’s other medical conditions and the clinical team’s preference.
Draining Cerebrospinal Fluid
Placing an external ventricular drain (EVD) is one of the most direct ways to relieve pressure. A thin catheter is inserted through a small hole in the skull into one of the brain’s fluid-filled chambers, allowing excess CSF to flow out into an external collection bag. This is frequently a lifesaving procedure in acute hydrocephalus or after traumatic brain injury.
The drain serves a dual purpose: it both monitors ICP in real time and treats it by removing fluid. In a randomized trial of traumatic brain injury patients, those managed with an EVD had far fewer episodes of pressure that couldn’t be controlled (21% vs. 52%) and better survival at both one and six months compared to patients monitored with a different type of probe that couldn’t drain fluid.
How the drain is managed matters. Some protocols keep the drain open continuously, allowing a steady trickle of CSF out. Others use an intermittent approach, opening the drain only when pressure exceeds a threshold. Continuous drainage may reduce pressure more consistently, while intermittent drainage may help the brain re-establish its own natural CSF circulation pathways. After a subarachnoid hemorrhage, guidelines recommend weaning the drain as quickly as possible to reduce the risk of infection, since every additional day with a catheter in the brain increases that risk.
Controlled Hyperventilation
When pressure is spiking acutely and other treatments need time to take effect, briefly increasing a patient’s breathing rate on a ventilator can provide a fast, temporary reduction. This works because lowering the level of carbon dioxide in the blood causes the brain’s small arteries to constrict, reducing the volume of blood in the skull and quickly dropping ICP.
The target is a blood carbon dioxide level of 30 to 35 mmHg, maintained for only 15 to 30 minutes. This is deliberately short-term because pushing carbon dioxide too low, or sustaining it there, starves the brain of blood flow. At levels between 20 and 25 mmHg, blood flow to the brain drops by 40 to 50%, which can cause oxygen deprivation and additional brain injury. For every 1 mmHg drop in carbon dioxide, brain blood flow decreases by about 3%. Hyperventilation is a bridge, not a solution, used to buy time while other treatments are started.
Barbiturate-Induced Coma
When pressure remains dangerously high despite all the measures above, medically inducing a deep coma with barbiturates can be considered. These drugs dramatically suppress brain activity, which reduces the brain’s demand for oxygen and fuel. Because blood flow to the brain is tightly linked to metabolic demand, lowering that demand causes blood vessels to constrict, reducing the total volume of blood in the skull and bringing pressure down.
This is a last-resort medical therapy. It requires intensive monitoring because barbiturates suppress not just brain function but also heart function and blood pressure. The patient is essentially kept in a controlled, deep unconscious state until the underlying cause of the pressure elevation can be addressed or resolves on its own.
Decompressive Craniectomy
If intracranial pressure remains uncontrollable despite all medical treatments, surgery to remove a section of the skull is the final option. This procedure, called decompressive craniectomy, gives the swelling brain room to expand outward rather than being compressed against the rigid skull. The bone flap is stored and replaced later, once swelling resolves, in a second surgery typically weeks to months afterward.
The most common reasons for this surgery are severe traumatic brain injury and large strokes that cause massive swelling. In the setting of trauma, it is specifically recommended when pressure is refractory to all medical management. Earlier surgery, ideally within the first 24 hours, is associated with better outcomes than delayed intervention. Among survivors, roughly 44% recover without major lasting disability, about a third have moderate disability, and a smaller percentage are left with severe disability or a vegetative state. This is a high-stakes procedure reserved for life-threatening situations, and outcomes depend heavily on the underlying cause and the patient’s condition before surgery.
Treating Idiopathic Intracranial Hypertension
Not all elevated intracranial pressure comes from an acute emergency. Idiopathic intracranial hypertension (IIH) is a chronic condition, most common in younger women with higher body weight, where pressure builds without a tumor, bleed, or blockage. The main risks are severe headaches and permanent vision loss from pressure on the optic nerves.
The cornerstone treatment is a medication called acetazolamide, which reduces the production of cerebrospinal fluid. It is typically started at 500 mg twice daily and can be increased up to 4 grams per day if needed and tolerated. In a major clinical trial, acetazolamide combined with a low-sodium diet and weight loss significantly improved vision and reduced pressure compared to diet alone. Weight loss is the single most important long-term strategy for IIH, and even modest weight reduction can lead to meaningful improvement. For patients whose vision deteriorates despite medication, procedures to divert CSF through a shunt or to relieve pressure on the optic nerve directly are available.
Treatment Thresholds and Goals
Current guidelines from the Brain Trauma Foundation, the most widely referenced standard for managing severe brain injuries, recommend treating ICP above 22 mmHg. This threshold is based on data showing a clear increase in mortality above that level. The treatment goal is to keep pressure below 22 mmHg while maintaining adequate blood flow to the brain, with a target cerebral perfusion pressure of 60 to 70 mmHg in adults.
Treatment decisions are rarely based on a single pressure number alone. Clinicians combine ICP readings with CT scans of the brain, neurological exams, and sometimes advanced monitoring of brain oxygenation to decide when and how aggressively to intervene. The Seattle International Severe Traumatic Brain Injury Consensus Conference developed a tiered system to guide this process: tier one covers basic measures like positioning and pain control, tier two adds osmotic therapy and CSF drainage, and tier three escalates to hyperventilation, barbiturates, and surgery. Each tier represents a step up in intensity, used only when the previous level fails to control pressure.